Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

NICO Corporation

United States·US-MF-000000769

Last updated September 17, 2026

Information

Country
United States
Address
96th Street, 250 East, Indianapolis, United States
LinkedIn
—
Facebook
—
Phone
+1 317 660 7118
PRRC Contact
—
EUDAMED SRN
US-MF-000000769
FDA FEI Number
3007456622
DUNS Number
829838288

Catalogue (143)

Page 1 of 3
DeviceModel / ReferenceRegistriesClassStatus
NICO BrainPath NN-7043
FDA UDI
Class IIActive
NICO Myriad NN-4018
FDA UDI
Class IActive
NICO BrainPath NN-8012
FDA UDI
Class IIActive
NICO BrainPath Approach NN-3004
FDA UDI
Class IActive
NICO Myriad NOVUS NN-7070
FDA UDI
Class IIActive
NICO BrainPath NN-8032
FDA UDI
Class IIActive
NICO BrainPath Approach NN-3001
FDA UDI
Class IActive
NICO BrainPath Approach NN-3000
FDA UDI
Class IActive
NICO Myriad-LX NN-1001
FDA UDI
Class IActive
NICO Myriad SPECTRA NN-7072
FDA UDI
Class IIActive
NICO BrainPath NN-7026
FDA UDI
Class IIActive
NICO Myriad NN-8003
FDA UDI
Class IIActive
NICO BrainPath NN-7035
FDA UDI
Class IIActive
NICO Myriad NN-8017
FDA UDI
Class IIActive
NICO BrainPath NN-7015
FDA UDI
Class IIActive
NICO BrainPath NN-7045
FDA UDI
Class IIActive
Myriad-LX NN-7023
FDA UDI
Class IIActive
NICO BrainPath NN-7037
FDA UDI
Class IIActive
NICO BrainPath Approach NN-2022
FDA UDI
Class IActive
NICO BrainPath NN-8013
FDA UDI
Class IIActive
NICO Myriad SPECTRA NN-7053
FDA UDI
Class IIActive
NICO BrainPath NN-7042
FDA UDI
Class IIActive
NICO Myriad NN-4004
FDA UDI
Class IActive
NICO Myriad NN-8005
FDA UDI
Class IIActive
NICO BrainPath NN-7016
FDA UDI
Class IIActive
NICO Myriad NN-1110
FDA UDI
Class IIActive
NICO BrainPath NN-7044
FDA UDI
Class IIActive
NICO TRIOwand NN-8028
FDA UDI
Class IIUnknown
NICO Myriad NN-4003
FDA UDI
Class IActive
NICO Myriad NN-7030
FDA UDI
Class IIActive
NICO Fluid System NN-8015
FDA UDI
Class IActive
NICO BrainPath NN-8033
FDA UDI
Class IIActive
NICO BrainPath NN-9007
FDA UDI
Class IActive
NICO BrainPath Approach NN-2003
FDA UDI
Class IActive
NICO Myriad NN-8008
FDA UDI
Class IIActive
NICO BrainPath Approach NN-2002
FDA UDI
Class IActive
NICO Myriad NN-8004
FDA UDI
Class IIActive
NICO BrainPath Approach NN-2001
FDA UDI
Class IActive
NICO BrainPath Approach NN-3008
FDA UDI
Class IActive
NICO BrainPath Approach NN-2005
FDA UDI
Class IActive
NICO BrainPath NN-7039
FDA UDI
Class IIActive
NICO BrainPath NN-7041
FDA UDI
Class IIActive
NICO meniGLIDE NN-8040
FDA UDI
Class IActive
NICO BrainPath NN-8031
FDA UDI
Class IIActive
NICO Myriad NN-8019
FDA UDI
Class IIActive
NICO Myriad NN-4017
FDA UDI
Class IActive
NICO Myriad NN-8020
FDA UDI
Class IIActive
NICO Myriad NOVUS NN-7012L
FDA UDI
Class IIActive
NICO BrainPath Approach NN-2006
FDA UDI
Class IActive
NICO BrainPath Approach NN-3006
FDA UDI
Class IActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (7)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Apr 30, 2021Z-1839-2021—terminated

(1) Updated IFU for the LX Illumination Packs: Warning - Avoid contact between the distal opening of the delivery sleeve and tissue/debris within the surgical.field to prevent complete occlusion. Some surgical approaches (e.g., endonasal) may increase this potential. {f unintended reduction in light output occurs and/or occlusion of the sleeve is suspected, both the delivery sleeve and the fiber should be replaced (2) Removal for the LX Light Source potential for the distal tip of the sleeve/fiber assembly potential to burn healthy tissue resulting in minor to moderate injury to the patient or end user.

Apr 30, 2021Z-1840-2021—terminated

(1) Updated IFU for the LX Illumination Packs: Warning - Avoid contact between the distal opening of the delivery sleeve and tissue/debris within the surgical.field to prevent complete occlusion. Some surgical approaches (e.g., endonasal) may increase this potential. {f unintended reduction in light output occurs and/or occlusion of the sleeve is suspected, both the delivery sleeve and the fiber should be replaced (2) Removal for the LX Light Source potential for the distal tip of the sleeve/fiber assembly potential to burn healthy tissue resulting in minor to moderate injury to the patient or end user.

Jun 19, 2018Z-2822-2018—terminated

Mislabeled hook pouch included a transport/storage label rather than the product label containing key product information such as part number, lot number, and expiration date, etc

Jul 29, 2015Z-2767-2015—terminated

Two cables within the console were inadvertently twisted during manufacturing. The individual wires within the cables may break and/or contact one another where the cables terminate into two connectors. When these wires break or contact one another (i.e., short), various types of malfunction may occur with the console. One type of malfunction may result in unexpected aspiration increase.

Feb 24, 2014Z-2045-2016—terminated

This recall has been initiated due to a defective component within the handpiece which will cause the handpiece to fail. The failure will result in the inability to cut tissue with the handpiece, rendering it non-functional. Should this failure occur, a replacement Myriad handpiece will be required. If a replacement handpiece is not available, alternate instrumentation for tissue removal will be necessary.

Jul 17, 2012Z-2201-2012—terminated

BrainPath sheaths were mislabeled. Sheaths which measure 50mm were labeled as 60mm. The length callout on the label does not match the actual length of the sheath within the packaging resulting in an improper fit as further explained below. This mislabeling was discovered on 29-June-2012 during a clinical case.

Jul 17, 2012Z-2200-2012—terminated

BrainPath sheaths were mislabeled. Sheaths which measure 50mm were labeled as 60mm. The length callout on the label does not match the actual length of the sheath within the packaging resulting in an improper fit as further explained below. This mislabeling was discovered on 29-June-2012 during a clinical case.